avatar for Dara Corrigan

Dara Corrigan

FDA Europe Office Director

Dara Corrigan heads the FDA’s Europe Office, located in Brussels. Ms. Corrigan serves as the FDA’s chief representative to the European Union (EU), working directly with the European Commission, European Medicines Agency and European Food Safety Agency. She also serves as liaison to FDA counterpart agencies in the 27 EU member States and in European countries outside the EU.  In addition, Ms. Corrigan serves as FDA’s link to the U.S. diplomatic community based in Europe.
Before taking over the Europe Office, Ms. Corrigan was the FDA’s Associate Commissioner for Regulatory Affairs.  In that position, she directed a staff of 4,000 employees across the United States and had responsibility for import safety, inspections, laboratory testing and enforcement policy for all FDA-regulated products.
Ms. Corrigan previously worked in the Office of Health Reform at the Department of Health and Human Services on the regulations that implemented the Affordable Care Act.  She was responsible for writing the first six regulations that served as the foundation for President Obama’s health reform efforts designed to provide universal health care coverage in the United States for the first time. 
Dara Corrigan began her career in the federal government in 1990 after graduating from the University of Virginia School of Law.  Following a judicial clerkship, she spent almost eight years as a trial attorney at the Department of Justice in the Civil Division and as an assistant United States attorney for the District of Columbia. 
She moved in 1999 to the Department of Health and Human Services to become the deputy chief counsel and director of program integrity for the Centers for Medicare and Medicaid Services.  She also served as the acting inspector general for the Department of Health and Human Services, where she managed a diverse staff of 1,600 auditors, attorneys, investigators and others, including investigative offices in every state.
Apart from her 20 years of public service, she joined the law firm of Arnold & Porter as a partner for three years, between 2004-2007, co-chairing its FDA and health care practice group.